Skip to main content
. Author manuscript; available in PMC: 2009 Oct 27.
Published in final edited form as: J Gerontol A Biol Sci Med Sci. 2008 Dec;63(12):1410–1415. doi: 10.1093/gerona/63.12.1410

Table 2.

Association of Depression and Antidepressant Use With Lower Spine Bone Mineral Density (g/cm2) for Entire Sample

Model 1
Model 2
Model 3
Variable Coefficient
(95% CI)
p Value Coefficient
(95% CI)
p Value Coefficient
(95% CI)
p Value
Lifetime MDD (ref. Never) −0.134
(−0.238, −0.029)
.012 −0.109
(−0.197, −0.022)
.014 −0.140
(−0.230, −0.049)
.003
Lifetime antidepressant use (ref. Never) 0.052
(−0.121, 0.226)
.554 0.067
(−0.073, 0.205)
.354
Sex × Antidepressant use (ref. Male, Never use) −0.204
(−0.402, −0.008)
.042 −0.218
(−0.398, −0.029)
.017

Notes: Model 1 is adjusted for age, race, and sex. Model 2 is adjusted for Model 1 plus lifetime antidepressant use and lifetime antidepressant use × sex. Model 3 is adjusted for Model 2 plus calcium use, smoking status, alcohol use, Physical Activity Scale for the Elderly score, and total percent fat. N = 94 for all models.

CI = confidence interval; MDD = major depressive disorder.

HHS Vulnerability Disclosure